{"id":"CHEMBL1007","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O","inchiKey":"XLXSAKCOAKORKW-AQJXLSMYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GONADORELIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fertiral lh-rh","Relefact lh-rh"],"synonyms":["Gonadorelin","Human gonadoliberin-i"],"crossReferences":{"chEBI":["5520"]},"childChemblIds":["CHEMBL1200516","CHEMBL1200511"],"count":3,"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0002610","EFO_0000545","EFO_0000731","MONDO_0007254","EFO_0000673","EFO_0003882","MONDO_0008315","Orphanet_478","MONDO_0018555","EFO_0001663"],"count":11},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 investigational indications."}
{"id":"CHEMBL1082738","canonicalSmiles":"c1ccc2c(NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)ccnc2c1","inchiKey":"UNVOAAWEEGAXTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1082738","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04616"]},"childChemblIds":["CHEMBL542236"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1092581","canonicalSmiles":"CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(CCO)S(C)(=O)=O)c(C3CC3)cc12","inchiKey":"WTDWVLJJJOTABN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NESBUVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HCV 796","HCV-796","Nesbuvir"],"crossReferences":{"drugbank":["DB07238"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1115","canonicalSmiles":"CN(C)C(=O)Oc1ccc[n+](C)c1","inchiKey":"RVOLLAQWKVFTGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PYRIDOSTIGMINE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mestinon","Pyridostigmine","Regonol"],"crossReferences":{"DailyMed":["pyridostigmine%20bromide"],"PubChem":["11111694","90340824"],"Wikipedia":["Pyridostigmine"],"drugbank":["DB00545"],"chEBI":["8665"]},"childChemblIds":["CHEMBL812","CHEMBL4303667"],"count":5,"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0005687","Orphanet_365","Orphanet_83419","MONDO_0100096","EFO_0003144","EFO_0000764","EFO_0002508","EFO_0005252","EFO_0004991","EFO_0000400","EFO_0005251"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL111861","canonicalSmiles":"C[C@]12CC(=O)[C@H]3[C@@H](CCC4=C[C@H](O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"LPYXTAPPNYMYOP-XDBTXSBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CORTISONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cortisone","NSC-9703"],"crossReferences":{"Wikipedia":["Cortisone"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL113194","canonicalSmiles":"CCCCn1c(Cc2cc(OC)ccc2OC)nc2c(N)ncnc21","inchiKey":"PPFZLLAIQRZNJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL113194","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02359"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160714","canonicalSmiles":"CC(C)NC[C@H](O)COc1ccc(O)cc1","inchiKey":"ADUKCCWBEDSMEB-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRENALTEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenol metabolite","Prenalterol"],"crossReferences":{"Wikipedia":["Prenalterol"],"drugbank":["DB13777"],"chEBI":["8391"]},"childChemblIds":["CHEMBL3085478"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL119709","canonicalSmiles":"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"HUJXGQILHAUCCV-MOROJQBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IB-MECA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IB-MECA"],"crossReferences":{"PubChem":["26752055","26752056","56463617","90341246"],"drugbank":["DB05511"],"chEBI":["73286"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1198191","canonicalSmiles":"CCCC(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=N)N)cc1","inchiKey":"RYAZZWWVNUWKNB-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198191","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06929"]},"childChemblIds":["CHEMBL3423003","CHEMBL598213"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1199324","canonicalSmiles":"C[C@@H](O[C@H]1OCCN(Cc2nn(P(=O)(O)O)c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"BARDROPHSZEBKC-OITMNORJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSAPREPITANT","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ivemend"],"synonyms":["Fosaprepitant","L-758298"],"crossReferences":{"DailyMed":["fosaprepitant%20dimeglumine"],"Wikipedia":["Fosaprepitant"],"drugbank":["DB06717"],"chEBI":["64321"]},"childChemblIds":["CHEMBL1201782","CHEMBL1159797"],"count":4,"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["MONDO_0001416","EFO_0000616","EFO_0006911","MONDO_0008170","HP_0002017","EFO_0004888","EFO_0001378","EFO_0004252","MONDO_0043510","EFO_0000691","EFO_0000311","MONDO_0002715"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 4 investigational indications."}
{"id":"CHEMBL1200424","canonicalSmiles":"O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Zn+2]","inchiKey":"HVASDHJNLYRZEA-UHFFFAOYSA-I","drugType":"Small molecule","blackBoxWarning":true,"name":"PENTETATE ZINC TRISODIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL780","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pentetate zinc trisodium"],"synonyms":["Pentetate Zinc Trisodium","Pentetate zinc trisodium"],"crossReferences":{"DailyMed":["pentetate%20zinc%20trisodium"],"DrugCentral":["4754"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2004. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200534","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O.Cl","inchiKey":"JXRAXHBVZQZSIC-JKVLGAQCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MOEXIPRIL HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1165","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Moexipril hydrochloride","Perdix","Univasc"],"synonyms":["CI 925","CI-925","Moexipril hydrochloride","RS-10085-197","SPM 925","SPM-925"],"crossReferences":{"DailyMed":["moexipril%20hydrochloride"],"PubChem":["144206143","170465131"]},"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995 and is indicated for hypertension. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200668","canonicalSmiles":"[Ca+2].[Cl-].[Cl-]","inchiKey":"UXVMQQNJUSDDNG-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM CHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cal Plus","Calcium Chloride Dihydrate"],"synonyms":["Calcium chloride","Calcium chloride dihydrate","Calcium chloride hydrate","E-509","E509","INS NO.509","INS-509"],"crossReferences":{"DailyMed":["calcium%20chloride"],"DrugCentral":["4201"],"PubChem":["144209783"],"Wikipedia":["Calcium_chloride"],"drugbank":["DB01164"],"chEBI":["3312"]},"childChemblIds":["CHEMBL2107795","CHEMBL2106539"],"count":6,"approvedIndications":["HP_0002901"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hypocalcemia and has 5 investigational indications."}
{"id":"CHEMBL1200791","canonicalSmiles":"Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1.Cl","inchiKey":"BEEDODBODQVSIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYMETAZOLINE HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL762","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Afrazine","Ocuclear","Rhofade","Upneeq","Visine","Visine l.r."],"synonyms":["Agn-199201","Oximetazoline hydrochloride","Oxymetazoline hydrochloride","SCH 9384","SCH-9384"],"crossReferences":{"DailyMed":["oxymetazoline%20hydrochloride"],"PubChem":["26747607","26747608","50106757","50106758","50106759","856146"],"chEBI":["7863"]},"count":5,"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0005854","MONDO_0001330","EFO_1000760","EFO_0009540","HP_0010783","EFO_1000906","EFO_0007141"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 5 investigational indications."}
{"id":"CHEMBL1200840","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)[C@H](O)[C@@H](O)C(=O)O","inchiKey":"WPTKISQJQVFSQI-LREBCSMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1200840","maximumClinicalTrialPhase":0,"parentId":"CHEMBL13","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["855895"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200965","canonicalSmiles":"CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C.Cl","inchiKey":"IWVTXAGTHUECPN-ANBBSHPLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BACAMPICILLIN HYDROCHLORIDE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1583","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ambaxin","Spectrobid"],"synonyms":["Bacampicillin hydrochloride"],"crossReferences":{"PubChem":["144204191","170465170","56463038"],"chEBI":["2969"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980 and has 1 investigational indication."}
{"id":"CHEMBL1201097","canonicalSmiles":"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1.Cl","inchiKey":"POUMFISTNHIPTI-BOMBIWCESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINCOMYCIN HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1447","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lincocin","Lincomycin HCl"],"synonyms":[],"crossReferences":{"PubChem":["170465252"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201120","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1.Cl","inchiKey":"WFBMIPUMYUHANP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"REMIFENTANIL HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1005","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ultiva"],"synonyms":["GI 87084B","GI-87084B","Remifentanil hydrochloride"],"crossReferences":{"DailyMed":["remifentanil%20hydrochloride"],"chEBI":["32091"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0005251"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1996. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201206","canonicalSmiles":"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H](N3CC[N+](C)(C)CC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CC[N+](C)(C)CC1","inchiKey":"OWWLUIWOFHMHOQ-XGHATYIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPECURONIUM","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pipecuronium"],"crossReferences":{"drugbank":["DB01338"],"chEBI":["8230"]},"childChemblIds":["CHEMBL1200722"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1201210","canonicalSmiles":"CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2","inchiKey":"UVOIBTBFPOZKGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPIOMAZINE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CB 1678","CB-1678","Dorevan","Dorevane","Indorm","Largon","Propavan","Propiomazine","WY-1359"],"crossReferences":{"Wikipedia":["Propiomazine"],"drugbank":["DB00777"],"chEBI":["8491"]},"childChemblIds":["CHEMBL1201068"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1201538","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN LISPRO","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Admelog","Admelog solostar","Humalog","Humalog kwikpen","Humalog pen","Humalog tempo pen","Ins humalog"],"synonyms":["Insulin Lispro Recombinant","Insulin lispro","Insulin lispro recombinant"],"crossReferences":{"DailyMed":["insulin%20lispro","insulin%20lispro%20recombinant","insulin%20lispro-aabc"],"DrugCentral":["5002"]},"count":4,"approvedIndications":["EFO_0000400"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0004593","EFO_0001359","EFO_0001645","EFO_0000401","HP_0003074","EFO_0001360","EFO_0000400"],"count":7},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for diabetes mellitus and has 3 investigational indications."}
{"id":"CHEMBL1201556","drugType":"Protein","blackBoxWarning":false,"name":"BECAPLERMIN","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Regranex"],"synonyms":["Becaplermin","GEM 21S","GEM-21S","Platelet-derived growth factor becaplermin","RWJ 60235","RWJ-60235"],"crossReferences":{"DailyMed":["becaplermin"],"DrugCentral":["4925"],"Wikipedia":["Becaplermin"]},"count":3,"approvedIndications":["HP_0200042"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000113721"],"count":2},"linkedDiseases":{"rows":["EFO_1001459","HP_0200042","MONDO_0043839","EFO_0005756"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for skin ulcer and has 2 investigational indications."}
{"id":"CHEMBL1231723","canonicalSmiles":"CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO","inchiKey":"ONJQDTZCDSESIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POLIDOCANOL","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Asclera","Varithena"],"synonyms":["Polidocanol","Polyoxyl 9 lauryl ether"],"crossReferences":{"DailyMed":["polidocanol"],"DrugCentral":["4614"],"PubChem":["144205947","170466791","29218048","50111750"],"drugbank":["DB06811"],"chEBI":["46859"]},"count":5,"approvedIndications":["MONDO_0001576","HP_0002619"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for telangiectasis and varicose veins and has 3 investigational indications."}
{"id":"CHEMBL1234363","canonicalSmiles":"OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"FYGDTMLNYKFZSV-PXXRMHSHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALTOTRIOSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206953"],"drugbank":["DB03277"],"chEBI":["27931"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235490","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@@H](O)C2","inchiKey":"CYHOMWAPJJPNMW-RNLVFQAGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSEUDOTROPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rel-Tropine"],"crossReferences":{"drugbank":["DB04026"],"chEBI":["15742"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237080","canonicalSmiles":"CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2.Cl","inchiKey":"QYZRTBKYBJRGJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRANISETRON HYDROCHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL289469","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Granisetron hydrochloride","Granisetron hydrochloride preservative free","Granisol","Granisteron HCl","Kytril"],"synonyms":["BRL 43694A","BRL-43694A","Granisetron hydrochloride"],"crossReferences":{"DailyMed":["granisetron%20hydrochloride"],"PubChem":["124894588"]},"count":5,"approvedIndications":["EFO_0006911","HP_0002017"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["HP_0100806","EFO_0000616","EFO_0006911","HP_0002017","HP_0002018"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for chemotherapy-induced nausea and vomiting and nausea and vomiting and has 3 investigational indications."}
{"id":"CHEMBL1255800","canonicalSmiles":"CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)O[C@H]1[C@H](O)[C@H](OC)[C@H](OC/C2=C\\C=C\\C[C@H](O)/C(C)=C/[C@H](CC)[C@@H](O[C@@H]3OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]3O)/C(C)=C/C(C)=C/C[C@@H]([C@@H](C)O)OC2=O)O[C@@H]1C","inchiKey":"ZVGNESXIJDCBKN-UUEYKCAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIDAXOMICIN","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dificid","Dificlir"],"synonyms":["Fidaxomicin","OPT-80","PAR-101"],"crossReferences":{"DailyMed":["fidaxomicin"],"Wikipedia":["Fidaxomicin"],"drugbank":["DB08874"]},"count":3,"approvedIndications":["HP_0002014"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for diarrhea and has 2 investigational indications."}
{"id":"CHEMBL1266","canonicalSmiles":"c1ccc2c(c1)CCCC2C1=NCCN1","inchiKey":"BYJAVTDNIXVSPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAHYDROZOLINE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tetrahydrozoline","Tetryzoline","Tyzine"],"crossReferences":{"PubChem":["90341828"],"Wikipedia":["Tetrahydrozoline"],"drugbank":["DB06764"],"chEBI":["28674"]},"childChemblIds":["CHEMBL1200413"],"count":3,"approvedIndications":["EFO_0005751","HP_0001742"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["MP_0001845","EFO_0000678","EFO_1000906","EFO_0005751","HP_0001742"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for eye allergy and nasal obstruction and has 1 investigational indication."}
{"id":"CHEMBL1324020","canonicalSmiles":"Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1.Cl.Cl","inchiKey":"VCTHNOIYJIXQLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1324020","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1623","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204048","170464899","26748110"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1355821","canonicalSmiles":"COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1","inchiKey":"WWJZWCUNLNYYAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMEFOS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["27165","Temefos"],"crossReferences":{"PubChem":["144205628","144212095","170466375","26757325","50111598","93576704"],"drugbank":["DB12231"],"chEBI":["38954"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1386","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANSPLATIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cisplatin","Platinol","Platinol-Aq"],"synonyms":["NSC-131558","Transplatin"],"crossReferences":{"PubChem":["124891673","26748616"],"chEBI":["27899"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL146095","canonicalSmiles":"O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12","inchiKey":"GWOFUCIGLDBNKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLAFENINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"," France"],"classes":["Immune system toxicity"],"year":1984},"tradeNames":[],"synonyms":["Glafenine","Glaphenine","Glycerylaminophenaquine","R 1707"],"crossReferences":{"PubChem":["26748455"],"chEBI":["31653"]},"childChemblIds":["CHEMBL1572751"],"count":2,"approvedIndications":["HP_0001945","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["HP_0001945","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for fever and pain. It was withdrawn in Germany and  France initially in 1984 due to Immune system toxicity."}
{"id":"CHEMBL1495","canonicalSmiles":"CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1","inchiKey":"DUDKAZCAISNGQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENCYCLIMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Oxyphencyclimine"],"crossReferences":{"drugbank":["DB00383"],"chEBI":["7868"]},"childChemblIds":["CHEMBL1200891"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL152067","canonicalSmiles":"CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1","inchiKey":"MXFWWQICDIZSOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALINOLOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Talinolol"],"crossReferences":{"PubChem":["144205724","170466514","26757961"],"Wikipedia":["Talinolol"],"drugbank":["DB11770"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL154232","canonicalSmiles":"[2H]c1cc(C(C)C)c(O)c(C(C)C)c1","inchiKey":"OLBCVFGFOZPWHH-UICOGKGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONODEUTERATED PROPOFOL","maximumClinicalTrialPhase":0,"parentId":"CHEMBL526","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Monodeuterated Propofol"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1543","canonicalSmiles":"N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O","inchiKey":"RWSXRVCMGQZWBV-WDSKDSINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTATHIONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glutathione"],"crossReferences":{"PubChem":["144204924","170465600"],"Wikipedia":["Glutathione"],"drugbank":["DB00143"],"chEBI":["16856"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1614637","canonicalSmiles":"CC(Oc1ccccc1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"NONJJLVGHLVQQM-JHXYUMNGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENETHICILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pheneticillin"],"crossReferences":{"Wikipedia":["Pheneticillin"],"drugbank":["DB13337"],"chEBI":["52427"]},"childChemblIds":["CHEMBL2364720"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL1643880","canonicalSmiles":"O=C(N[C@H]1CN2CCC1CC2)c1c[nH]c2ccsc2c1=O","inchiKey":"AFUWQWYPPZFWCO-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PUMOSETRAG","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DDP733","Pumosetrag"],"crossReferences":{"drugbank":["DB12402"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1651026","canonicalSmiles":"CC(C)C[C@H](NC(=O)CN(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCS(C)(=O)=O)C(N)=O","inchiKey":"OUPXSLGGCPUZJJ-SARDKLJWSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL1651026","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05875"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1673148","canonicalSmiles":"C[N+](C)(CCOc1ccccc1)Cc1ccccc1.O=C([O-])c1cc2ccccc2cc1O","inchiKey":"PMPQCPQAHTXCDK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BEPHENIUM HYDROXYNAPHTHOATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alcopar"],"synonyms":["Bephene oxinaphtoate","Bephenium embonate","Bephenium hydroxynaphthoate"],"crossReferences":{"Wikipedia":["Bephenium_hydroxynaphthoate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1697830","canonicalSmiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"VUHJZBBCZGVNDZ-TTYLFXKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORMADINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlormadinone"],"crossReferences":{"PubChem":["144206541"],"TG-GATEs":["126"],"drugbank":["DB13528"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1736","canonicalSmiles":"CC(=O)Nc1c(I)c(C(=O)O)c(I)c(N(C)C(C)=O)c1I","inchiKey":"GGGDNPWHMNJRFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METRIZOIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Metrizoate","Metrizoic acid"],"crossReferences":{"PubChem":["50125803"],"Wikipedia":["Metrizoic_acid"],"drugbank":["DB09346"],"chEBI":["34847"]},"childChemblIds":["CHEMBL2364738","CHEMBL1200353","CHEMBL1200423","CHEMBL2068723"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1742424","canonicalSmiles":"CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1.Cl","inchiKey":"VKJHTUVLJYWAEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CELIPROLOL HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL27810","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Celectol","Selecor"],"synonyms":["Celiprolol hydrochloride"],"crossReferences":{"PubChem":["144206275","170465958"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1743067","drugType":"Antibody","blackBoxWarning":false,"name":"SAMALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALXN-6000","ALXN6000","Samalizumab"],"count":4,"linkedTargets":{"rows":["ENSG00000091972"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000095","EFO_0000222","EFO_0001378"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1780010","canonicalSmiles":"COc1cc2c(cc1OCCC[18F])CCN1C[C@@H](CC(C)C)[C@H](O)C[C@H]21","inchiKey":"GNKGXQHHUUEYQV-WTHAECTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORBENAZINE F 18","maximumClinicalTrialPhase":2,"parentId":"CHEMBL579217","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(18F)AV 133","(18F)AV-133","18F-AV-133","AV-133 F-18","Florbenazine (18f)","Florbenazine f 18"],"crossReferences":{"drugbank":["DB14945"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL180971","canonicalSmiles":"C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O","inchiKey":"IWHCAJPPWOMXNW-LYKMMFCUSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PEPTIDE T","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Peptide t"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL187718","canonicalSmiles":"CCCc1c(OC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O","inchiKey":"BNZHKKGOSYAQSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL187718","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07867"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1900528","canonicalSmiles":"C[N+]1(C)[C@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"LERNTVKEWCAPOY-DZZGSBJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOTROPIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Braltus","Spiriva","Spiriva respimat"],"synonyms":["Tiotropium"],"crossReferences":{"DailyMed":["tiotropium%20bromide"],"PubChem":["50113015"],"drugbank":["DB01409"]},"childChemblIds":["CHEMBL4440620","CHEMBL3545181"],"count":1,"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["HP_0000083","HP_0006536","EFO_0000270","EFO_0000464","EFO_0006505","EFO_1001919","Orphanet_586","EFO_0000341","MONDO_0004784"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2004 and has 1 investigational indication."}
{"id":"CHEMBL198408","canonicalSmiles":"COc1ccc(O)cc1NC(=O)NC(=O)c1ccc(F)cc1Cl","inchiKey":"RFOBTYLRURSVJE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL198408","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07968"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL20210","canonicalSmiles":"CCOC(=O)/C=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)c1cc(C)on1)C(C)C)Cc1ccc(F)cc1","inchiKey":"CAYJBRBGZBCZKO-BHGBQCOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUPINTRIVIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG7088","Rupintrivir"],"crossReferences":{"drugbank":["DB05102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL204593","canonicalSmiles":"Cc1cc(S(=O)(=O)N[C@@H](C(=O)NO)C2CCOCC2)ccc1F","inchiKey":"LUCFRFDOOYLALP-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL204593","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2063869","canonicalSmiles":"CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1snnc1-c1ccccc1)C1CCCCC1","inchiKey":"WZRFLSDVFPIXOV-LRQRDZAKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GDC-0152","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gdc-0152"],"crossReferences":{"drugbank":["DB12380"]},"childChemblIds":["CHEMBL2063872","CHEMBL2063871"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2088494","canonicalSmiles":"Br.c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1","inchiKey":"ZEGBUIHJZHQADU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2088494","maximumClinicalTrialPhase":0,"parentId":"CHEMBL18442","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2093880","canonicalSmiles":"CCCCCCCC(=O)OC[C@@H](O)[C@@H](OC)[C@@H]1OC(C(=O)O)=C[C@H](N[14C](=N)N)[C@H]1NC(C)=O","inchiKey":"UKTIJASCFRNWCB-NRNKPVEJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2093880","maximumClinicalTrialPhase":0,"parentId":"CHEMBL467058","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103799","canonicalSmiles":"CC[C@H](C)CC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1","inchiKey":"SDDSJMXGJNWMJY-BRHAQHMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COBIPROSTONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cobiprostone","RU-8811","SPI-8811"],"crossReferences":{"drugbank":["DB05514"]},"count":3,"linkedTargets":{"rows":["ENSG00000114859"],"count":1},"linkedDiseases":{"rows":["EFO_0004607","EFO_0000666","EFO_1001904"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2103811","canonicalSmiles":"Nc1nc(=O)c2c([nH]1)NCC1CN(c3ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc3)CN21.[Ca+2]","inchiKey":"AKUPTUNGFOADRT-ZEDZUCNESA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FOLITIXORIN CALCIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL117348","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANX-510","COFACTOR","Folitixorin calcium"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2103829","canonicalSmiles":"CN(C)C[C@@H]1CCCC[C@H]1c1cccc(O)c1","inchiKey":"JIRYWFYYBBRJAN-ZFWWWQNUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAXELADOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EM-906","EM906","Faxeladol","GCR-9905","GCR9905","GRT-TA300","GRTA-0009906","GRTA-9906","GRTA0009906","GRTA9906","Grt9906"],"childChemblIds":["CHEMBL3893776"],"count":3,"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0005762","EFO_0005687","HP_0012532"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2103847","canonicalSmiles":"CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO","inchiKey":"FWFGIHPGRQZWIW-SQNIBIBYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOSEDOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHR 2797","CHR-2797","Tosedostat"],"crossReferences":{"drugbank":["DB11781"]},"count":5,"linkedTargets":{"rows":["ENSG00000002549","ENSG00000172901","ENSG00000196236","ENSG00000164307","ENSG00000215440","ENSG00000138792","ENSG00000141279","ENSG00000176393","ENSG00000111142","ENSG00000164308","ENSG00000166825","ENSG00000123992","ENSG00000113441","ENSG00000142327","ENSG00000108039","ENSG00000172878","ENSG00000148120","ENSG00000164024","ENSG00000122121"],"count":19},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0002618","EFO_0000222","EFO_0003060"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2103858","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1CCN(CCCCCC(=O)O[C@H]2CN3CCC2CC3)C[C@@H]1OC","inchiKey":"VGDDOIZXGFJDRC-VJTSUQJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NARONAPRIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATI-7505","Naronapride"],"crossReferences":{"drugbank":["DB05542"]},"childChemblIds":["CHEMBL2105706"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["HP_0012450"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2103901","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O","inchiKey":"QSIRXSYRKZHJHX-TWXHAJHVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SINAPULTIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATI 01","Sinapultide"],"crossReferences":{"drugbank":["DB11332"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104306","canonicalSmiles":"OCCN(CCO)c1nc(-c2ccccc2)c(-c2ccccc2)o1","inchiKey":"UUCMDZWCRNZCOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DITAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ditazole","S-222"],"crossReferences":{"drugbank":["DB08994"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104578","canonicalSmiles":"O=C(O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O","inchiKey":"UVAUYSRYXACKSC-ULQDDVLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILAZAPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cilazaprilat","RO 31-3113"],"crossReferences":{"drugbank":["DB15565"],"chEBI":["81005"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104627","canonicalSmiles":"O=[N+]([O-])c1ccc(/C=C/c2cccc(CO)n2)o1","inchiKey":"JQKHJQJVKRFMCO-SNAWJCMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFURPIRINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Furanace"],"synonyms":["Nifurpirinol","P-7138"],"crossReferences":{"drugbank":["DB11436"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105567","canonicalSmiles":"NC(=O)c1cc[n+](CC2=C(C(=O)[O-])N3C(=O)[C@@H](NC(=O)Cc4cccs4)[C@H]3SC2)cc1","inchiKey":"FMZXNVLFJHCSAF-DNVCBOLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFALONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["41071","Cefalonium","Cephalonium"],"crossReferences":{"PubChem":["144204099","170466431"],"drugbank":["DB11385"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105864","canonicalSmiles":"COc1ccc(C[C@@H](CN[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](Cc2cccs2)NC(=O)CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CCCN=C(N)N)cc1","inchiKey":"IDXCXSCCZNCXCL-XMADEQCMSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LABRADIMIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Labradimil","Lobradimil","RMP-7"],"crossReferences":{"drugbank":["DB06549"]},"count":3,"linkedTargets":{"rows":["ENSG00000168398"],"count":1},"linkedDiseases":{"rows":["EFO_0007228","EFO_0002939","EFO_1000158"],"count":3},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105950","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"BYHDFCISJXIVBV-YWUHCJSESA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AMOXICILLIN SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1082","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amoxicillin sodium","BRL-2333AB-B"],"crossReferences":{"chEBI":["51255"]},"count":2,"approvedIndications":["EFO_0003106","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pneumonia and infection."}
{"id":"CHEMBL2106537","canonicalSmiles":"Cc1cc(CCN2CCN(c3cccc(Cl)c3)CC2)n[nH]1","inchiKey":"DOTIMEKVTCOGED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPIPRAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mepiprazole"],"crossReferences":{"drugbank":["DB09197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107355","canonicalSmiles":"Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O","inchiKey":"ZJIHMALTJRDNQI-OLALXQGDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIGALASTAT HYDROCHLORIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL110458","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Galafold"],"synonyms":["AT-1001 (MIGALASTAT HYDROCHLORIDE)","Migalastat hydrochloride"],"crossReferences":{"DailyMed":["migalastat%20hydrochloride"]},"count":1,"approvedIndications":["Orphanet_324"],"linkedTargets":{"rows":["ENSG00000102393"],"count":1},"linkedDiseases":{"rows":["Orphanet_324"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for fabry disease."}
{"id":"CHEMBL2107398","canonicalSmiles":"N[C@@H](Cc1cc([125I])c(Oc2ccc(O)c([125I])c2)c([125I])c1)C(=O)O","inchiKey":"AUYYCJSJGJYCDS-QBYPCAMJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIOTHYRONINE I 125","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1544","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Triomet-125"],"synonyms":["Liothyronine i 125"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107793","canonicalSmiles":"CC[C@@H](OC(C)=O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"XBMIVRRWGCYBTQ-XMSQKQJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPHACETYLMETHADOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alphacemethadone","Alphacetylmethadol"],"crossReferences":{"drugbank":["DB01555"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107802","canonicalSmiles":"Cc1cc(S(C)(=O)=O)c(S(C)(=O)=O)cc1C(=O)NC(=N)N","inchiKey":"GROMEQPXDKRRIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMEPORIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rimeporide"],"crossReferences":{"drugbank":["DB12861"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107877","drugType":"Protein","blackBoxWarning":false,"name":"BLISIBIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-623","AMG 623","AMG-623","Blisibimod"],"count":5,"linkedTargets":{"rows":["ENSG00000102524"],"count":1},"linkedDiseases":{"rows":["EFO_0007160","EFO_0002690","EFO_0005297","EFO_0004194","EFO_1000784"],"count":5},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108045","drugType":"Antibody","blackBoxWarning":false,"name":"PRITUMUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pritumumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108110","drugType":"Unknown","blackBoxWarning":false,"name":"THROMBIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thrombostat"],"synonyms":["Thrombin"],"count":11,"approvedIndications":["MP_0001914"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and has 10 investigational indications."}
{"id":"CHEMBL2108287","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"APRINOCARSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aprinocarsen","LY-900003","LY900003","Ly900003"],"count":1,"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108305","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN TREGOPIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IN-105","Insulin tregopil"],"count":3,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108335","drugType":"Gene","blackBoxWarning":false,"name":"SITIMAGENE CERADENOVEC","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sitimagene ceradenovec"],"count":1,"description":"Gene drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108510","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON BETA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avonex","Extavia","Interf b 1a","Interf b 1b","Interfb1a","Rebif"],"synonyms":["Fibroblast interferon","Interferon beta","Interferon beta natural"],"count":5,"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108545","drugType":"Unknown","blackBoxWarning":false,"name":"ORGOTEIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Orgotein","Sod","Superoxide dismutase"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108572","drugType":"Protein","blackBoxWarning":false,"name":"BALUGRASTIM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balugrastim","CG-10639","CG10639"],"count":1,"linkedTargets":{"rows":["ENSG00000119535"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109067","drugType":"Enzyme","blackBoxWarning":false,"name":"KALLIDINOGENASE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Padutin"],"synonyms":["Kallidinogenase","Kallidinogenase (human urine)"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2109211","drugType":"Unknown","blackBoxWarning":false,"name":"MEASLES VIRUS VACCINE LIVE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Attenuvax"],"synonyms":["Measles virus vaccine live","Measles, live attenuated"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109224","drugType":"Antibody","blackBoxWarning":false,"name":"ROVELIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Leukarrest"],"synonyms":["HU23F2G","Rovelizumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109286","drugType":"Antibody","blackBoxWarning":false,"name":"COLTUXIMAB RAVTANSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coltuximab ravtansine","SAR-3419","SAR3419"],"count":3,"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["EFO_0000220","EFO_0000403","EFO_0005952"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109295","drugType":"Antibody","blackBoxWarning":false,"name":"ASCRINVACUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ascrinvacumab","PF-03446962"],"count":4,"linkedTargets":{"rows":["ENSG00000139567"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000770","EFO_0000182","EFO_1001951"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109332","drugType":"Antibody","blackBoxWarning":false,"name":"MLNM-2201","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LDP-01","MLNM-2201"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109360","drugType":"Antibody","blackBoxWarning":false,"name":"AS-1403","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Therafab"],"synonyms":["AS-1403"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109544","drugType":"Antibody","blackBoxWarning":false,"name":"CDP-860","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDP-860"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2111135","canonicalSmiles":"CC(CN1c2ccccc2Sc2ccccc21)[N+](C)(C)C","inchiKey":"CDXCCYNINPIWGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAZINAMIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thiazinam"],"crossReferences":{"drugbank":["DB13420"]},"childChemblIds":["CHEMBL2107499","CHEMBL2146061"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111152","canonicalSmiles":"CC(Cc1ccccc1)NCCn1cnc2c1c(=O)n(C)c(=O)n2C","inchiKey":"NMCHYWGKBADVMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENETHYLLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenethylline","Fenetylline"],"crossReferences":{"drugbank":["DB01482"]},"childChemblIds":["CHEMBL2107591"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2178720","canonicalSmiles":"O=c1nc(NO)ccn1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"XCUAIINAJCDIPM-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2178720","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15660"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL22108","canonicalSmiles":"CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1","inchiKey":"MVMQESMQSYOVGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHINDENE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dimetindene"],"crossReferences":{"Wikipedia":["Dimetindene"],"drugbank":["DB08801"]},"childChemblIds":["CHEMBL1870768"],"count":2,"approvedIndications":["HP_0000989","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_0004269","EFO_0003785"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for allergy and pruritus."}
{"id":"CHEMBL2220384","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCC=CC1N(C)C","inchiKey":"WDEFBBTXULIOBB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tilidine"],"crossReferences":{"chEBI":["77817"]},"childChemblIds":["CHEMBL2218854"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL23327","canonicalSmiles":"CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1","inchiKey":"PMXCMJLOPOFPBT-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PURVALANOLA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piceatannol","Purvalanol A","Purvalanola"],"crossReferences":{"PubChem":["11111629","11114140"],"drugbank":["DB04751"],"chEBI":["47600"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364638","canonicalSmiles":"C[C@@H]1[C@H](c2ccccc2)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F","inchiKey":"DDOOFTLHJSMHLN-ZQHRPCGSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UBROGEPANT","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ubrelvy"],"synonyms":["MK-1602","Ubrogepant"],"crossReferences":{"DailyMed":["ubrogepant"],"drugbank":["DB15328"]},"count":1,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["EFO_0003821"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and is indicated for migraine disorder."}
{"id":"CHEMBL238071","canonicalSmiles":"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1","inchiKey":"HHJUWIANJFBDHT-ZVTSDNJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINDESINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["COMPOUND 112531","COMPOUND-112531","Vindesine"],"crossReferences":{"drugbank":["DB00309"]},"childChemblIds":["CHEMBL3989543"],"count":14,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 13 investigational indications."}
{"id":"CHEMBL24","canonicalSmiles":"CC(C)NCC(O)COc1ccc(CC(N)=O)cc1","inchiKey":"METKIMKYRPQLGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ATENOLOL","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antipressan","Atenamin","Atenix-100","Atenix-25","Atenix-50","Atenolol","Ibinolo","Kentol","Tenormin","Tenormin 25","Tenormin l.s.","Totamol","Unibloc","Vasaten"],"synonyms":["Atenolol","C07AB03","Esatenolol","ICI 66,082","ICI 66082","ICI-66082"],"crossReferences":{"DailyMed":["atenolol"],"PubChem":["144212743","26751696","50085956","50104387","855957","90340978"],"Wikipedia":["Atenolol"],"drugbank":["DB00335"],"chEBI":["2904"]},"count":16,"approvedIndications":["EFO_0000319","EFO_0000612","EFO_0000537","EFO_0003913"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0007372","EFO_0004214","EFO_0003777","EFO_0000275","EFO_0005323","EFO_0000401","EFO_0001358","EFO_0000319","Orphanet_558","EFO_0003882","EFO_0000537","EFO_0003913","EFO_0003914","EFO_0003896","EFO_1001375","EFO_0003144","EFO_1002032","EFO_0000612","EFO_0003763","EFO_1000635"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 4 approved and 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL242237","canonicalSmiles":"NC(=O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1","inchiKey":"QHPKKGUGRGRSGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL242237","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07268"],"chEBI":["40332"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24778","canonicalSmiles":"C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F","inchiKey":"PNCPYILNMDWPEY-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SILODOSIN","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rapaflo"],"synonyms":["KAD-3213","KMD-3213","Silodosin"],"crossReferences":{"DailyMed":["silodosin"],"Wikipedia":["Silodosin"],"drugbank":["DB06207"]},"count":3,"approvedIndications":["EFO_0000284"],"linkedTargets":{"rows":["ENSG00000120907"],"count":1},"linkedDiseases":{"rows":["EFO_0004253","EFO_1001228","EFO_0000284","EFO_0003830","HP_0000011","MONDO_0008315"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for benign prostatic hyperplasia and has 2 investigational indications."}
{"id":"CHEMBL259352","canonicalSmiles":"CCCCCCCC(=O)N[C@H]1CCOC1=O","inchiKey":"JKEJEOJPJVRHMQ-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL259352","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07928"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL260933","canonicalSmiles":"CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(CC)c1=O","inchiKey":"KOYXXLLNCXWUNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GS 6201","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CVT-6883","Gs 6201"],"crossReferences":{"PubChem":["103905523","174007167"],"drugbank":["DB05936"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL272427","canonicalSmiles":"C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"BHTRKEVKTKCXOH-LBSADWJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAURURSODIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taurursodiol","Ursodeoxy Cholic Acid"],"crossReferences":{"Wikipedia":["Tauroursodeoxycholic_acid"],"drugbank":["DB08834"],"chEBI":["80774"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282146","canonicalSmiles":"CC(C)C[C@H](CC(=O)O)C(=O)N[C@H]1Cc2cn(c3ccccc23)CCCCCCNC1=O","inchiKey":"AKWKBACKRMYPRV-NQIIRXRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL282146","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08493"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL28472","canonicalSmiles":"N[C@@H](CC1=CCCCc2onc(O)c21)C(=O)O","inchiKey":"HJEPOXZLPHUVFE-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL28472","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04152"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL285063","canonicalSmiles":"C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1","inchiKey":"HTUBKQUPEREOGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-168393","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-168393"],"crossReferences":{"drugbank":["DB07662"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3125456","canonicalSmiles":"[2H]C([2H])(c1ccc(OC([2H])([2H])C([2H])([2H])[2H])cc1)c1cc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)ccc1Cl","inchiKey":"JVHXJTBJCFBINQ-UGSGERFESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3125456","maximumClinicalTrialPhase":0,"parentId":"CHEMBL429910","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137321","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(OC(=O)c4ccccc4)=CC[C@@H]4[C@@H](C2)N(C)CC[C@@]341","inchiKey":"VPMRSLWWUXNYRY-NDOYXKHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZHYDROCODONE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benzhydrocodone"],"crossReferences":{"DailyMed":["benzhydrocodone%20hydrochloride"],"drugbank":["DB15465"]},"childChemblIds":["CHEMBL3137310"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018."}
{"id":"CHEMBL3186011","canonicalSmiles":"COCC1(CO)C(=O)C2CCN1CC2","inchiKey":"BGBNULCRKBVAKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APR-246","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apr 246","Apr-246"],"crossReferences":{"PubChem":["174007096"],"drugbank":["DB11684"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL325041","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O","inchiKey":"GXJABQQUPOEUTA-RDJZCZTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BORTEZOMIB","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Velcade"],"synonyms":["Bortezomib","Bortezomib hydrate","LDP-341","NSC-681239","PS-341","Velcade"],"crossReferences":{"DailyMed":["bortezomib"],"PubChem":["124950705","144206183","144206225","170465087","518755"],"Wikipedia":["Bortezomib"],"drugbank":["DB00188"],"chEBI":["52717"]},"count":99,"approvedIndications":["EFO_0000616","EFO_0001378","EFO_1001469","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000100804"],"count":1},"linkedDiseases":{"rows":["EFO_0004708","EFO_0000756","EFO_0000681","EFO_0005952","EFO_1001052","EFO_0000308","Orphanet_85443","EFO_1001951","EFO_0000339","EFO_0000096","EFO_0000588","MONDO_0002974","MONDO_0008903","EFO_0003884","EFO_0000641","MONDO_0015277","EFO_0000198","MONDO_0013730","EFO_0002618","MONDO_0019465","EFO_0001642","EFO_1001968","EFO_1001946","MONDO_0008627","MONDO_0008315","EFO_0001663","MONDO_0019139","EFO_1001365","EFO_0003032","EFO_0000574","EFO_0004256","EFO_0001378","Orphanet_207073","EFO_1000550","MONDO_0015564","EFO_0003073","EFO_0000292","EFO_0007183","MONDO_0003175","EFO_1001465","MONDO_0007254","EFO_0000255","EFO_0004252","MONDO_0003541","MONDO_0020654","MONDO_0001056","MONDO_0002158","EFO_0000326","EFO_0002499","EFO_0000183","EFO_0000707","EFO_0000616","EFO_0006859","MONDO_0019457","EFO_0000403","EFO_0000222","EFO_1001875","MONDO_0007576","EFO_0004599","EFO_1001961","Orphanet_238510","EFO_0002517","EFO_1001947","MONDO_0002367","MONDO_0018906","MONDO_0024880","EFO_0000519","MONDO_0000873","EFO_0000571","MONDO_0000956","EFO_0002426","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0007160","Orphanet_365","MONDO_0019460","EFO_0000182","EFO_0000501","EFO_0007332","EFO_0000094","EFO_1000785","EFO_0009441","EFO_0000220","MONDO_0008170","MONDO_0044881","EFO_0000224","EFO_0002428","EFO_1001051","Orphanet_314701","MONDO_0009348","MONDO_0019471","MONDO_0004192","MONDO_0015686","EFO_1001469","EFO_0000209","MONDO_0002087","EFO_0000305","EFO_0000231","MONDO_0001187","EFO_0000673","EFO_1000158","EFO_0002501","EFO_0003060","EFO_0000621","EFO_0006738","EFO_0000311","EFO_0000211","MONDO_0001705","EFO_0000095","EFO_0006475","EFO_1001936","EFO_0000191","EFO_1001226","EFO_0000691","EFO_0003811"],"count":116},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 4 approved and 95 investigational indications."}
{"id":"CHEMBL3264610","canonicalSmiles":"CC(C)[C@](O)(c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1)c1c[nH]nn1","inchiKey":"ZBRAJOQFSNYJMF-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEVITERONEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Seviteronel"],"crossReferences":{"drugbank":["DB12275"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3301582","drugType":"Antibody","blackBoxWarning":false,"name":"POLATUZUMAB VEDOTIN","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Polivy"],"synonyms":["ACD-79B-VCMMAE","ACD-79BVCMMAE","ACD79B-VCMMAE","DCDS-4501A","DCDS4501A","FCU-2711","FCU2711","Polatuzumab vedotin","Polatuzumab vedotin-piiq","RG-7596","RG7596","RO-5541077-000","RO-5541077000","RO5541077-000"],"crossReferences":{"DailyMed":["polatuzumab%20vedotin-piiq"]},"count":6,"approvedIndications":["EFO_0000403"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000007312","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["MONDO_0044889","EFO_0000096","EFO_0000095","EFO_0000403","EFO_0000574","MONDO_0018906","EFO_0005952"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for diffuse large b-cell lymphoma and has 5 investigational indications."}
{"id":"CHEMBL3301605","canonicalSmiles":"O.O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O","inchiKey":"TWFRCSHLWKJBQH-UXQCFNEQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELEBACTAM","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3112741","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["MK-7655","MK-7655 MONOHYDRATE","Relebactam","Relebactam hydrate","Relebactam monohydrate"],"count":7,"approvedIndications":["EFO_0003103","EFO_0000544","EFO_1001141"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL3392104","canonicalSmiles":"Cl.Cl[Te]1(Cl)OCCO1.N","inchiKey":"VSJCJBQENUBFJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMMONIUM TRICHLORO(DIOXOETHYLENE-O,O'-)TELLURATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL3546168","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ammonium trichloro(dioxoethylene-o,o'-)tellurate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3544911","canonicalSmiles":"COc1cccc(OCCCN)c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1","inchiKey":"DOTGPNHGTYJDEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREXASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY2606368","Prexasertib"],"crossReferences":{"drugbank":["DB12008"]},"count":15,"linkedTargets":{"rows":["ENSG00000183765","ENSG00000149554"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_1001779","MONDO_0008170","EFO_0002939","EFO_0000222","EFO_0000708","EFO_0003060","EFO_0000311","EFO_0009708","MONDO_0001657","EFO_0004142","EFO_0000702","EFO_0004284","EFO_1000158"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 15 investigational indications."}
{"id":"CHEMBL3544956","drugType":"Small molecule","blackBoxWarning":false,"name":"PYROTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyrotinib","SHR-1258"],"count":6,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","EFO_0003869","EFO_0005537","MONDO_0007254","EFO_0003060"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3545080","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7256","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PLX-3603","Rg-7256","Ro-5212054"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545144","drugType":"Small molecule","blackBoxWarning":false,"name":"TAS-115","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tas-115"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545211","canonicalSmiles":"CCN(CC)Cc1ccc(OCC[C@H]2CCC3C4C(CC[C@@]32C)c2ccc(O)cc2C[C@H]4C)c(OC)c1","inchiKey":"OHCPNHFLPCVWRG-YQOGLFJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SR16234","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3545210"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545292","drugType":"Small molecule","blackBoxWarning":false,"name":"QBW251","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Qbw251"],"count":2,"linkedTargets":{"rows":["ENSG00000001626"],"count":1},"linkedDiseases":{"rows":["Orphanet_586","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545344","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05212377","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-05212377","PF-5212377","Pf-05212377","SAM-760","WYE-103760"],"count":1,"linkedTargets":{"rows":["ENSG00000158748"],"count":1},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707288","canonicalSmiles":"O=C([O-])CCC(=O)[O-].[Li+].[Li+]","inchiKey":"WAHQBNXSPALNEA-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"LITHIUM SUCCINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lithium succinate"],"crossReferences":{"DrugCentral":["4590"],"drugbank":["DB14508"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707335","canonicalSmiles":"CC(=O)CC(=O)[O-].CC(=O)CC(=O)[O-].CC(=O)CC(=O)[O-].[Al+3]","inchiKey":"DEVXQDKRGJCZMV-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINIUM ACETOACETATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1230762","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aluminium acetoacetate"],"crossReferences":{"DrugCentral":["4761"],"drugbank":["DB13280"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707348","canonicalSmiles":"CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12","inchiKey":"WDENQIQQYWYTPO-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACALABRUTINIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calquence"],"synonyms":["ACP-196","Acalabrutinib","Acp-196"],"crossReferences":{"DailyMed":["acalabrutinib"],"drugbank":["DB11703"]},"childChemblIds":["CHEMBL4594293"],"count":16,"approvedIndications":["EFO_0000616","EFO_1001469"],"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["MONDO_0044887","EFO_1001469","EFO_0005952","EFO_0000096","MONDO_0019088","MONDO_0004695","MONDO_0002083","EFO_0009441","EFO_0002618","MONDO_0013730","EFO_0000685","EFO_0000616","MONDO_0008170","EFO_0000403","EFO_0000222","MONDO_0044881","EFO_0003060","EFO_0000311","EFO_0005741","MONDO_0100096","MONDO_0044889","MONDO_0001023","EFO_0000095","EFO_0000574","EFO_0001378","MONDO_0018906","EFO_0000519","EFO_0000181"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for neoplasm and mantle cell lymphoma and has 14 investigational indications."}
{"id":"CHEMBL376388","canonicalSmiles":"CNCc1ccc(-c2ncnc3[nH]cnc23)cc1","inchiKey":"VRGSDHJXBVCQEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL376388","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07854"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3764429","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O.[K+]","inchiKey":"VZFABNLZPKZBGG-TWDWGCDDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3764429","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1747","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL384467","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"UREBDLICKHMUKA-CXSFZGCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXAMETHASONE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aeroseb-dex","Dalalone","Decaderm","Decadron","Decadron-75","Decaspray","Dexacortisyl","Dexafree","Dexamethasone","Dexamethasone intensol","Dexone","Dexone 0.5","Dexone 0.75","Dexone 1.5","Dexone 4","Dexsol","Dextenza","Dexycu kit","Dropodex","Gppe ear spy","Hemady","Hexadrol","Kortico Injection","Martapan","Maxidex","Maxitrol","Oradexon","Otomize","Ozurdex","Sofradex","Spersadex comp","Tobradex"],"synonyms":["Decadron-LA","Dexacen-4","Dexacort","Dexair","Dexamethasone","Dexamethasone metasulfobenzoate sodium","Dexamethasone palmitate","Dexamethasone valerate","Fluormethylprednisolone","ISV-305","Mymethasone","NSC-34521","Neodecadron","OTO-104"],"crossReferences":{"DailyMed":["dexamethasone"],"PubChem":["144207320","17389945","26752876","26752877","26752878","56314873","56320685","92119"],"Wikipedia":["Dexamethasone"],"drugbank":["DB01234"],"chEBI":["41879"]},"count":255,"approvedIndications":["EFO_0000729","EFO_0004274","EFO_0005558","EFO_1000797","EFO_0008997","EFO_0000565","EFO_0007160","EFO_0009456","EFO_0007520","EFO_0002506","EFO_0002690","EFO_0000544","EFO_0004255","EFO_0000676","EFO_0009552","EFO_0004276","EFO_0004719","HP_0003072","EFO_0005854","EFO_0009449","EFO_1000039","HP_0001742","HP_0001873","EFO_0000384","EFO_1001119","Orphanet_418","MP_0001845","EFO_1000049","Orphanet_90794","EFO_0000270","EFO_0000574","EFO_1001051","HP_0012424","MONDO_0003005","EFO_1001896","EFO_0007405","EFO_1001494","EFO_1000997","EFO_1001205","EFO_0005319","EFO_1000764","MONDO_0001280","EFO_1001435","HP_0001094","EFO_0003778","EFO_1000684","EFO_0000274","HP_0001915","EFO_0003966","HP_0004398","EFO_1000694","EFO_0005752","EFO_0009609","Orphanet_797","EFO_0000616","EFO_0000685","MONDO_0015128","EFO_0003898","EFO_0003770","EFO_0003894","EFO_1000941","EFO_0002609","EFO_0000311","EFO_0003106","EFO_0003885","EFO_0007257","EFO_0007403","EFO_1001194","EFO_0007141","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0010822","MONDO_0100130","EFO_0000681","EFO_0009536","EFO_0005952","EFO_0009322","EFO_1001129","EFO_0005773","EFO_1001909","EFO_1000797","EFO_1001951","MONDO_0001416","EFO_0003103","MONDO_0001903","EFO_0000588","EFO_0009560","EFO_0002690","MONDO_0016047","EFO_1001366","EFO_0000096","EFO_0008528","EFO_0000676","EFO_0008517","EFO_0000400","HP_0003072","EFO_0000221","EFO_0009686","EFO_1000811","HP_0012532","EFO_0009449","HP_0009926","EFO_1001946","EFO_0000546","MONDO_0002691","MONDO_0044889","EFO_0009688","EFO_1000049","EFO_0003957","MONDO_0016226","MONDO_0002406","EFO_0001378","EFO_0000341","EFO_0000516","MONDO_0015564","EFO_0003073","EFO_1001896","EFO_0001365","EFO_0004992","EFO_1000684","Orphanet_790","EFO_1001012","EFO_0007297","EFO_1000637","MONDO_0003541","MONDO_0004565","MONDO_0000465","EFO_0003966","MONDO_0001056","EFO_0009430","MONDO_0002050","EFO_1000694","EFO_0000196","EFO_0007231","EFO_0000183","EFO_1001417","MONDO_0002083","EFO_0005752","HP_0002094","HP_0000486","EFO_0008590","EFO_0000403","EFO_0003898","HP_0011110","MONDO_0007576","EFO_1001875","EFO_0001358","EFO_0000618","HP_0003418","EFO_0003843","HP_0002315","EFO_1002002","EFO_0007149","MONDO_0011962","EFO_0000702","EFO_1001947","MONDO_0024880","EFO_0004710","MONDO_0000873","EFO_0004683","EFO_0007200","EFO_0001075","EFO_0005592","EFO_0004274","EFO_1000657","EFO_0002426","EFO_0000565","EFO_0000309","EFO_0007160","EFO_0009456","EFO_0007520","EFO_0004253","EFO_1000786","MONDO_0015540","EFO_0009552","EFO_0007541","MONDO_0004768","EFO_1002012","EFO_1000749","EFO_0004719","EFO_0003802","EFO_0009441","EFO_0005296","EFO_0003893","MONDO_0002122","EFO_1000039","MONDO_0021144","MONDO_0044881","HP_0001873","EFO_1001119","MP_0001845","EFO_1000986","HP_0030833","EFO_0004888","EFO_0003785","EFO_0006862","MONDO_0019471","EFO_1001494","EFO_1001984","EFO_1000764","MONDO_0044887","MONDO_0001280","EFO_1001435","HP_0001094","EFO_1001469","HP_0001915","MONDO_0001187","HP_0004398","MONDO_0001718","Orphanet_70589","EFO_0009507","HP_0002017","MONDO_0001657","EFO_0004212","EFO_0004272","EFO_0003932","EFO_0007427","HP_0002015","EFO_0003917","EFO_0009321","EFO_0007490","EFO_0009609","EFO_0009869","MONDO_0015128","EFO_0007344","EFO_0003894","EFO_0000613","EFO_0003060","EFO_0006912","EFO_0006738","EFO_0007228","EFO_0007227","EFO_0001068","EFO_0000095","EFO_0006475","EFO_0007403","EFO_1001936","EFO_0005611","EFO_0003027","EFO_0003811","EFO_0005539","EFO_0004190","Orphanet_64739","EFO_0004708","EFO_0000365","EFO_0007486","EFO_0000275","EFO_0000756","MONDO_0002959","MONDO_0018896","HP_0011868","Orphanet_85443","HP_0011950","EFO_0003964","EFO_1000992","EFO_1000318","EFO_0003931","MONDO_0008903","EFO_0003884","EFO_0004616","MONDO_0002331","EFO_0000198","MONDO_0013730","EFO_0002618","EFO_0006911","EFO_1000906","EFO_0001642","EFO_0005323","EFO_1001968","HP_0001742","EFO_0000384","MONDO_0008315","EFO_0005221","EFO_0001663","EFO_0009448","EFO_0001422","MP_0001914","EFO_0003032","EFO_0000678","MONDO_0019472","EFO_0000574","MONDO_0002258","EFO_0003086","EFO_0007405","EFO_1000997","EFO_1001205","MONDO_0021108","EFO_0002913","MONDO_0007254","EFO_0009657","EFO_0000284","EFO_0004252","EFO_0009760","EFO_0003959","EFO_0009514","EFO_0004289","Orphanet_1930","EFO_0004238","EFO_0009625","EFO_1002005","Orphanet_797","EFO_0000616","EFO_0000694","EFO_1000829","EFO_1001779","EFO_0006859","EFO_1001157","MONDO_0000870","EFO_0000222","EFO_1001267","EFO_0000537","EFO_1001961","EFO_0003885","EFO_0007257","EFO_0000684","EFO_1001194","EFO_0007141","MONDO_0018906","MONDO_0001572","EFO_0009515","EFO_0003956","EFO_0000729","EFO_1000845","EFO_0003869","EFO_0008571","EFO_0009373","EFO_1000131","EFO_0005558","HP_0002018","EFO_0008997","EFO_0002506","EFO_0000544","MONDO_0002471","MONDO_0019460","EFO_0000182","EFO_0000330","EFO_0004255","EFO_1001176","EFO_0004208","EFO_0007332","EFO_0006510","HP_0012378","EFO_0000094","EFO_0004276","EFO_1001250","EFO_0005854","EFO_0000220","EFO_0003821","MONDO_0008170","EFO_0000223","Orphanet_3389","EFO_0004236","EFO_0000224","EFO_0003025","Orphanet_418","EFO_0009708","MONDO_0100096","Orphanet_90794","EFO_0000270","MONDO_0044917","EFO_1001051","HP_0012424","EFO_0000218","Orphanet_314701","EFO_0000699","EFO_1001115","EFO_0005251","MONDO_0009348","MONDO_0037255","MONDO_0003005","EFO_0001059","EFO_0006951","EFO_0003812","EFO_0005319","EFO_1000965","Orphanet_232","EFO_1001945","EFO_0003778","EFO_0000373","EFO_0000209","EFO_0000274","EFO_0000708","MONDO_0002462","EFO_0000305","MONDO_0020657","EFO_1001480","EFO_1001216","EFO_1001801","HP_0030834","EFO_1001830","EFO_0000673","HP_0002013","MONDO_0020743","EFO_1000726","EFO_0010580","MONDO_0009410","EFO_0000685","EFO_0000545","EFO_0005207","EFO_0003770","EFO_0005755","EFO_1000941","EFO_0002609","EFO_0000311","EFO_0004237","EFO_0003106","EFO_0000211","EFO_0005570","MONDO_0001705","MONDO_0016093","EFO_0000706","EFO_0000691","EFO_0000181","EFO_0001063"],"count":343},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1958 and has 70 approved and 185 investigational indications."}
{"id":"CHEMBL3989408","canonicalSmiles":"CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.O.O.[Na+]","inchiKey":"VTGPMVCGAVZLQI-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"IBUPROFEN SODIUM","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL521","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Advil","Ibuprofen sodium"],"synonyms":["Ibuprofen sodium"],"crossReferences":{"DailyMed":["ibuprofen%20sodium"]},"count":1,"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2012 and has 1 investigational indication."}
{"id":"CHEMBL3989927","canonicalSmiles":"O=C1CC[C@H](N2Cc3c(OCc4ccc(CN5CCOCC5)cc4)cccc3C2=O)C(=O)N1","inchiKey":"IXZOHGPZAQLIBH-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBERDOMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iberdomide"],"crossReferences":{"drugbank":["DB12101"]},"childChemblIds":["CHEMBL3989912"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3989937","canonicalSmiles":"CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F.Cl.Cl.O","inchiKey":"COWBUPJEEDYWKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPMATINIB HYDROCHLORIDE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3188267","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tabrecta"],"synonyms":["Capmatinib hydrochloride","NVP-INC280-AAA"],"crossReferences":{"DailyMed":["capmatinib%20hydrochloride"]},"count":1,"approvedIndications":["EFO_0003060"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for non-small cell lung carcinoma."}
{"id":"CHEMBL3989980","drugType":"Antibody","blackBoxWarning":false,"name":"LARCAVIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zmapp"],"synonyms":["Larcaviximab","c4G7"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL410807","canonicalSmiles":"CC[C@H]1C[C@H](C)[C@@]2(NC1=O)O[C@@H](C[C@H](O)[C@@H](C)CC/C=C/C=C(\\C)[C@@H]1C/C=C/C=C/[C@H](O)[C@H](C)[C@@H](O)[C@@H](CCC(C)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc3cccc(O)c3)C(=O)N3CCC[C@H](N3)C(=O)O1)[C@H](C)[C@H](O)[C@@H]2C","inchiKey":"ONJZYZYZIKTIEG-CFBQITSMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SANGLIFEHRIN A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03393"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4129286","canonicalSmiles":"CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@@]1(F)O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(O)[C@@H]1O)Oc1ccccc1","inchiKey":"NIJYGVDQZBBONK-SEUXLIJBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADAFOSBUVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-335","Adafosbuvir","Al-335","JNJ-335"],"crossReferences":{"drugbank":["DB14906"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297214","canonicalSmiles":"OC(CNc1nc(-c2cc(-c3ccon3)n(Cc3ccccc3F)n2)ncc1F)(C(F)(F)F)C(F)(F)F","inchiKey":"CYSJNTQNMDWAJV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRALICIGUAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IW-1973","Praliciguat"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297286","canonicalSmiles":"C[C@@H]1CN(c2ccc(F)cc2C(F)(F)F)CCN1S(=O)(=O)c1cccc([C@@](C)(O)C(F)(F)F)c1","inchiKey":"ZWASRJHIEFYJGL-BFUOFWGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HSD-016","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hsd-016"],"crossReferences":{"drugbank":["DB12419"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297357","canonicalSmiles":"N[C@H](Cc1ccc(OC[18F])cc1)C(=O)O","inchiKey":"GEBHVOHKNWLITQ-DEVVULMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-FLUOROMETHYLTYROSINE F-18","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4302826","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 86-9596","BAY-86-9596","BAY-86-9596 F-18","BAY-869596","BAY-869596-","BAY86-9596","Bay86-9596","D-fluoromethyltyrosine f-18","J2.566.882K"],"crossReferences":{"drugbank":["DB15296"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297376","canonicalSmiles":"Cc1ccc(NS(=O)(=O)c2cccc(C#N)c2)c2[nH]cc(C#N)c12","inchiKey":"LWGUASZLXHYWIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E-7820","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-7820","E7820","ER-68203-00"],"crossReferences":{"drugbank":["DB12505"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297383","canonicalSmiles":"Fc1cc(-c2cccc(-c3nc[nH]n3)c2)cc(F)c1CNC1Cc2ccccc2C1","inchiKey":"WIEDUMBCZQRGSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-1521498","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK1521498","Gsk-1521498","Gsk1521498"],"crossReferences":{"drugbank":["DB12886"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297421","canonicalSmiles":"O=C(Nc1nc(-c2ccc(O)c(O)c2)c(-c2ccccc2)s1)c1ccc(O)c(O)c1","inchiKey":"LGGDLPSXAGQFSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COH-29","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COH29","Coh-29","Rnr inhibitor coh29"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297458","canonicalSmiles":"Cc1nnn(C)c1-c1cnc2c3ccc(C(C)(C)O)cc3n([C@H](c3ccccc3)C3CCOCC3)c2c1","inchiKey":"KGERZPVQIRYWRK-GDLZYMKVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-986158","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986158","Bms-986158"],"crossReferences":{"drugbank":["DB15435"]},"count":2,"linkedTargets":{"rows":["ENSG00000169925","ENSG00000204256","ENSG00000137948","ENSG00000141867"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000574"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297512","canonicalSmiles":"O=C[C@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"BYZQBCIYLALLPA-NOPGXMAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GAXILOSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gaxilose"],"crossReferences":{"drugbank":["DB12767"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297702","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-936559","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-936559","MDX-1105","MDX1105"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297778","drugType":"Antibody","blackBoxWarning":false,"name":"LONCASTUXIMAB TESIRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADCT-402","ADCT-402 TESIRINE","Adct-402 tesirine","Loncastuximab tesirine"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297825","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"SEVUPARIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DF-02","DF02","Sevuparin"],"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297942","drugType":"Antibody","blackBoxWarning":false,"name":"QUETMOLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-6011","E6011","Quetmolimab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298048","drugType":"Unknown","blackBoxWarning":false,"name":"MP-0250","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MP-0250","MP0250","Mp-0250","Mp0250"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298055","drugType":"Protein","blackBoxWarning":false,"name":"ALDAFERMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aldafermin","NGM-282","NGM282","Ngm282"],"count":6,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4298065","drugType":"Unknown","blackBoxWarning":false,"name":"OMEGA-3 FATTY ACIDS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NDI 441","Omega 3 fatty acids","Omega-3 fatty acids","Omega-3 triglycerides","Phospholipids"],"count":8,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL4298082","drugType":"Unknown","blackBoxWarning":false,"name":"RECOMBINANT NEMATODE ANTICOAGULANT PROTEIN C2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Recombinant nematode anticoagulant protein c2","Recombinant nematode anticoagulant protein c2 (rnapc2)","Rnapc2"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298104","drugType":"Unknown","blackBoxWarning":false,"name":"CBS-9106","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CBS-9106","Cbs-9106","Felezonexor","S-03747","SL-801","Sl-801"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL430","canonicalSmiles":"CO/N=C1\\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN","inchiKey":"ZRCVYEYHRGVLOC-HYARGMPZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GEMIFLOXACIN","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Gemifloxacin"],"crossReferences":{"DailyMed":["gemifloxacin%20mesylate"],"Wikipedia":["Gemifloxacin"],"drugbank":["DB01155"],"chEBI":["101853"]},"childChemblIds":["CHEMBL1200621"],"count":4,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for bacterial disease and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL436774","canonicalSmiles":"CC(=O)N1CCC(NC(=O)NC23CC4CC(CC(C4)C2)C3)CC1","inchiKey":"HUDQLWBKJOMXSZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AR9281","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ar9281"],"crossReferences":{"drugbank":["DB06345"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL445","canonicalSmiles":"CNCCC=C1c2ccccc2CCc2ccccc21","inchiKey":"PHVGLTMQBUFIQQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NORTRIPTYLINE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Allegron","Aventyl","Motipress","Motival"],"synonyms":["NCI-169453","Nortriptyline","Pamelor"],"crossReferences":{"DailyMed":["nortriptyline%20hydrochloride"],"PubChem":["11110653","11110654","124878449","152146160","26747092","26747093","4253930","50100156","50104257","50104258","90340759"],"Wikipedia":["Nortriptyline"],"drugbank":["DB00540"],"chEBI":["7640"]},"childChemblIds":["CHEMBL1201156"],"count":12,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0000555","HP_0000726","EFO_0003768","EFO_1002014","EFO_0000274","EFO_1000948","EFO_0008533","EFO_0003948","EFO_0009562","EFO_0000289","MONDO_0002050","EFO_0008524","EFO_0000676","EFO_0003761","EFO_0009854","MONDO_0043510","EFO_0005279","EFO_0005230","EFO_0000692"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for unipolar depression and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL449158","canonicalSmiles":"CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3","inchiKey":"MJQUEDHRCUIRLF-TVIXENOKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRYOSTATIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bryostatin","Bryostatin 1"],"crossReferences":{"PubChem":["144206307"],"chEBI":["88353"]},"count":25,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 25 investigational indications."}
{"id":"CHEMBL45305","canonicalSmiles":"Cc1ccc(CNCC2(F)CCN(C(=O)c3ccc(F)c(Cl)c3)CC2)nc1","inchiKey":"PKZXLMVXBZICTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEFIRADOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Befiradol","F-13640","F13640","NLX-112"],"crossReferences":{"Wikipedia":["Befiradol"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4584552","canonicalSmiles":"COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC.O=S(=O)([O-])c1ccccc1","inchiKey":"GLLXELVDCIFBPA-UHFFFAOYSA-M","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4584552","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1360","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594444","canonicalSmiles":"C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1","inchiKey":"AZXOTZCWQDJCLY-SJCJKPOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PECAVAPTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY 1753011","BAY-1753011","Bay 1753011","Pecavaptan"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594459","drugType":"Unknown","blackBoxWarning":false,"name":"APG-1387","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APG-1387","APG-1387 (SMAC MIMETIC)","Apg-1387","SM-1387"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594461","drugType":"Unknown","blackBoxWarning":false,"name":"AUTOLOGOUS CORD BLOOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Autologous cord blood","Autologous human umbilical cord blood","Autologous umbilical cord blood"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4594518","drugType":"Antibody","blackBoxWarning":false,"name":"LUTIKIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-1234138","ABT-981","Abt-981","Lutikizumab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594599","drugType":"Enzyme","blackBoxWarning":false,"name":"GLUTAMATE DECARBOXYLASE 2","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glutamate decarboxylase 2","Rhgad65"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594600","drugType":"Unknown","blackBoxWarning":false,"name":"HUMAN NEUREGULIN-1 RECOMBINANT (177-237)","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Human neuregulin-1 recombinant (177-237)","Rhnrg-1"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL460291","canonicalSmiles":"CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C","inchiKey":"GKQPCPXONLDCMU-CCEZHUSRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LACIDIPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Caldine","Molap","Motens"],"synonyms":["GR 43659X","GR-43659X","Lacidipine"],"crossReferences":{"PubChem":["144205727","170465580"],"drugbank":["DB09236"]},"count":3,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL464345","canonicalSmiles":"O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"RGHNJXZEOKUKBD-SQOUGZDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUCONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E574"],"crossReferences":{"PubChem":["144209943"],"Wikipedia":["Gluconic_acid"],"drugbank":["DB13180"],"chEBI":["33198"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL477508","canonicalSmiles":"O=c1[nH]c(=O)c2c([nH]1)n(C[C@H](O)[C@H](O)[C@H](O)CO)c(=O)n2CCCOP(=O)(O)O","inchiKey":"KPHFGOGGKPGLTM-OOZYFLPDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL477508","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL483465","canonicalSmiles":"Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc3c(cc21)OCO3","inchiKey":"FARXPFGGGGLENU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"9-ING-41","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-ing-41"],"count":11,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL488025","canonicalSmiles":"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\\c1ccc(S(C)(=O)=O)cc1","inchiKey":"MVGSNCBCUWPVDA-MFOYZWKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EXISULIND","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Exisulind","Sulindac related compound b","Sulindac sulfone"],"crossReferences":{"PubChem":["11111778","144207073","170466321","50107023","85231220"],"drugbank":["DB06246"],"chEBI":["64212"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL49","canonicalSmiles":"O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1","inchiKey":"QWCRAEMEVRGPNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUSPIRONE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BCI-024","Buspar","Buspirone"],"crossReferences":{"DailyMed":["buspirone%20hydrochloride"],"PubChem":["104171117","11110857","11112732","11113821","144203643","144212688","170464909","26751994","90340780"],"Wikipedia":["Buspirone"],"drugbank":["DB00490"],"chEBI":["3223"]},"childChemblIds":["CHEMBL1200399"],"count":16,"approvedIndications":["EFO_0005230"],"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","EFO_0003756","EFO_0004240","EFO_0002610","HP_0002140","EFO_0006788","MONDO_0002009","EFO_0002508","HP_0000726","EFO_0003758","EFO_1001919","EFO_1000948","EFO_0008533","EFO_0007191","EFO_0004714","MONDO_0002050","HP_0002045","EFO_0004888","EFO_0005230","EFO_0000692","HP_0002104","EFO_0000717","EFO_0005411"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for anxiety and has 15 investigational indications."}
{"id":"CHEMBL501259","canonicalSmiles":"CCCCCC/C=C\\CCCCCCCCCC(=O)N[C@H]1[C@H](OC[C@H]2O[C@H](OP(=O)(O)O)[C@H](NC(=O)CC(=O)CCCCCCCCCCC)[C@@H](OCCCCCCCCCC)[C@@H]2O)O[C@H](COC)[C@@H](OP(=O)(O)O)[C@@H]1OCC[C@@H](CCCCCCC)OC","inchiKey":"BPSMYQFMCXXNPC-MFCPCZTFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERITORAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E5564","Eritoran"],"crossReferences":{"Wikipedia":["Eritoran"],"drugbank":["DB04933"],"chEBI":["68609"]},"childChemblIds":["CHEMBL3301672"],"count":1,"linkedTargets":{"rows":["ENSG00000154589","ENSG00000136869"],"count":2},"linkedDiseases":{"rows":["EFO_0003106","HP_0100806","EFO_0000565","MONDO_0100096","EFO_0002614","EFO_0007328"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL510539","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"FSBUXLDOLNLABB-ISAKITKMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL510539","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208143","17389021"],"drugbank":["DB15488"],"chEBI":["4745"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL528988","canonicalSmiles":"CCCCOc1ccc2cc(S(=O)(=O)N[C@H](CCC(=O)O)C(=O)O)ccc2c1","inchiKey":"UAGYXJBYAFGRFR-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL528988","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08106"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL541253","canonicalSmiles":"Cc1ccc(S(=O)(=O)O)cc1","inchiKey":"JOXIMZWYDAKGHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"P-Toluenesulfonate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P-Toluenesulfonate"],"crossReferences":{"PubChem":["144209562"],"Wikipedia":["P-Toluenesulfonic_acid"],"drugbank":["DB03120"],"chEBI":["27849"]},"childChemblIds":["CHEMBL3183883"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL543191","canonicalSmiles":"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21.Cl","inchiKey":"BPYZIOINRAWEQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAZEPAM HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL12","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL55","canonicalSmiles":"N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1","inchiKey":"XDRYMKDFEDOLFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAMIDINE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nebupent [as isethionate]","Pentacarinat","Pentacarinat [as isethionate]","Pentam 300 [as isethionate]"],"synonyms":["GNF-Pf-3680","MB 800 FREE BASE","MB 800 [AS ISETHIONATE]","MB-800","MB-800 (AS ISETHIONATE)","MB-800 FREE BASE","NSC-9921","Pentamidine","Pentamidine isetionate","RP 2512 FREE BASE","RP 2512 [AS ISETHIONATE)","RP-2512","RP-2512 FREE BASE"],"crossReferences":{"DailyMed":["pentamidine%20isethionate"],"PubChem":["50123735","50123736","75273"],"Wikipedia":["Pentamidine"],"drugbank":["DB00738"],"chEBI":["45081"]},"childChemblIds":["CHEMBL935","CHEMBL543544","CHEMBL494163","CHEMBL361506"],"count":11,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 11 investigational indications."}
{"id":"CHEMBL561360","canonicalSmiles":"CC(C)N(c1cc(-c2ccccc2)sc1C(=O)O)C(=O)[C@H]1CC[C@H](C)CC1","inchiKey":"RZXQBIKGWSLVEK-JCNLHEQBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL561360","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08279"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL573043","canonicalSmiles":"[2H][C@@](CCC)(NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1","inchiKey":"BBAWEDCPNXPBQM-FRYYVICASA-N","drugType":"Protein","blackBoxWarning":false,"name":"D-Telaprevir","maximumClinicalTrialPhase":0,"parentId":"CHEMBL231813","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Telaprevir"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL573077","canonicalSmiles":"COc1cc(-c2c(C)cccc2C)cc([C@@H](C)C#Cc2c(C)nc(N)nc2N)c1","inchiKey":"XZXVRKHUCSXVBM-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL573077","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07144"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL60745","canonicalSmiles":"CC[N+](C)(C)c1cccc(O)c1.[Br-]","inchiKey":"CAEPIUXAUPYIIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDROPHONIUM BROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1104","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edrophonium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL615","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"BPLBGHOLXOTWMN-MBNYWOFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN V","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["V-cillin"],"synonyms":["Penapar-VK","Penicillin phenoxymethyl","Penicillin v","Penicillin-VK","Phenomycilline","Phenoxymethylpenicillin","Veetids"],"crossReferences":{"DailyMed":["penicillin%20v%20potassium"],"PubChem":["29215255"],"Wikipedia":["Phenoxymethylpenicillin"],"drugbank":["DB00417"],"chEBI":["27446"]},"childChemblIds":["CHEMBL1396177","CHEMBL2103963","CHEMBL1200852"],"count":3,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1958 and is indicated for bacterial disease and has 2 investigational indications."}
{"id":"CHEMBL70421","canonicalSmiles":"CC(C)[C@@H](NC(=O)[C@H](CS)NC(=O)CCC[C@H](N)C(=O)O)C(=O)O","inchiKey":"BYEIJZFKOAXBBV-ATZCPNFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL70421","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02025"],"chEBI":["28496"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL82202","canonicalSmiles":"Cc1ncc(COP(=O)(O)O)c(C=O)c1O","inchiKey":"NGVDGCNFYWLIFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRIDOXAL PHOSPHATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-82388","Pyridoxal 5-phosphate","Pyridoxal 5-phosphate monohydrate","Pyridoxal Phosphate","Pyridoxal phosphate","Pyridoxal phosphate hydrate"],"crossReferences":{"PubChem":["29218058"],"Wikipedia":["Pyridoxal_phosphate"],"drugbank":["DB00114"],"chEBI":["18405"]},"childChemblIds":["CHEMBL3989490","CHEMBL3181870"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL893","canonicalSmiles":"Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"YFAGHNZHGGCZAX-JKIFEVAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICLOXACILLIN","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BRL-1702","Dicloxacillin","Dycill","Dynapen","Pathocil","R-13423"],"crossReferences":{"DailyMed":["dicloxacillin%20sodium"],"PubChem":["124893598"],"Wikipedia":["Dicloxacillin"],"drugbank":["DB00485"],"chEBI":["4511"]},"childChemblIds":["CHEMBL1200701","CHEMBL26570"],"count":4,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and is indicated for bacterial disease and has 3 investigational indications."}
{"id":"CHEMBL898","canonicalSmiles":"O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O","inchiKey":"HUPFGZXOMWLGNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DIFLUNISAL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diflunisal","Dolobid","Dolobid 500"],"synonyms":["Diflunisal"],"crossReferences":{"DailyMed":["diflunisal"],"PubChem":["11112675","124882514","144204149","170464956","26746997","855794"],"Wikipedia":["Diflunisal"],"drugbank":["DB00861"],"chEBI":["39669"]},"count":4,"approvedIndications":["HP_0001945","EFO_0003843"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0000764","HP_0001945","EFO_0001360","EFO_0003843","Orphanet_85447"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for pain and fever and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL90488","canonicalSmiles":"CN(C)S(=O)(=O)N1CCN(c2ccnc(CO)n2)CC1","inchiKey":"XDTHNROWHAAVPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-166572","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-166572"],"crossReferences":{"drugbank":["DB04478"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL93298","canonicalSmiles":"CC(C)(C)NCC(O)CSc1nc(-c2ccc(C(N)=O)s2)cs1","inchiKey":"BHIAIPWSVYSKJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AROTINOLOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arotinolol","Arotinolol hydrochloride"],"crossReferences":{"Wikipedia":["Arotinolol"],"drugbank":["DB09204"]},"childChemblIds":["CHEMBL3185966"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL946","canonicalSmiles":"CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1","inchiKey":"SEBMTIQKRHYNIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZATADINE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Azatadine","Optimine","Trinalin"],"crossReferences":{"PubChem":["144206535","170464865"],"Wikipedia":["Azatadine"],"drugbank":["DB00719"],"chEBI":["2946"]},"childChemblIds":["CHEMBL3544908"],"count":1,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003785"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977 and is indicated for allergy."}
{"id":"CHEMBL993","canonicalSmiles":"Cc1c[nH]c(=O)[nH]c1=O","inchiKey":"RWQNBRDOKXIBIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THYMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thymine"],"crossReferences":{"Wikipedia":["Thymine"],"drugbank":["DB03462"],"chEBI":["17821"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
